Jeffrey C Johnson

Title: The Innovative Contributions of Jeffrey C. Johnson

Introduction

Jeffrey C. Johnson, an accomplished inventor based in Carlsbad, CA, has made significant contributions to the field of biomedicine. He holds a valuable patent that addresses a critical need for therapies with reduced immunogenicity, making important strides in antibody development.

Latest Patents

Johnson is credited with a patent titled "Antibodies with Low Immunogenicity and Uses Thereof." This innovative patent presents antibodies and antigen-binding fragments that exhibit low or no immunogenicity in humans, along with desirable manufacturing properties. The patent details compositions that include these antibodies or fragments, methods for utilizing such antibodies, and methodologies for their production.

Career Highlights

Currently, Johnson is affiliated with Celgene Corporation, a company renowned for its focus on innovation in biopharmaceuticals. His role at Celgene showcases his dedication to advancing medical science and therapeutics.

Collaborations

Throughout his career, Johnson has collaborated with esteemed colleagues such as Lawrence Dearth and Haralambos Hadjivassiliou. These partnerships illustrate a team-driven approach to research and development, enhancing the scope and impact of their collective work.

Conclusion

Jeffrey C. Johnson's contributions to the field of antibody research and development demonstrate his commitment to improving therapeutic outcomes. His patent on low immunogenicity antibodies is a testament to his innovative spirit and dedication to advancing health science. As he continues his work at Celgene Corporation, the potential for future breakthroughs remains promising.